Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / Mar / OCTA Overview
Retina

OCTA Overview

TVST review highlights the significant advances made over the last decade in optical coherence tomography angiography

By The Ophthalmologist 3/25/2025 3 min read

Share

0325-012-AI-news-OCTA-Overview-InArticle.png

M.O. Stevens, CC BY-SA 3.0 <https://creativecommons.org/licenses/by-sa/3.0>, via Wikimedia Commons


A TVST review has explored the significant advancements made in optical coherence tomography angiography (OCTA) since the modality was first introduced into clinical practice in 2015. In the last decade, OCTA has revolutionized eye care by providing high-resolution images of microvascular structures, enabling early detection and monitoring of conditions such as diabetic retinopathy, macular degeneration, and glaucoma.

Key technological improvements considered by the Casey Eye Institute researchers include the expanded field of view allowed by newer wide-field OCTA technologies; advances in swept-source lasers and Fourier domain processing that have significantly improved imaging speed and resolution; AI-based models that can be used to analyze and interpret OCTA data; and the development of handheld OCTA devices.

All of these advancements make OCTA a powerful tool for early disease detection, treatment monitoring, and research into retinal conditions, the authors say. The combination of faster imaging, AI-assisted analysis, and wider field capabilities has made OCTA more accessible and practical for everyday clinical use. The review observes that, as imaging technology continues to evolve, OCTA can be expected to play an even more crucial role in research and clinical technology.

About the Author(s)

The Ophthalmologist

More Articles by The Ophthalmologist

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: